Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 12, Issue 5, Pages 533-544
Publisher
Informa Healthcare
Online
2016-03-16
DOI
10.1517/17425255.2016.1166204
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Successful treatment of methicillin-resistant Staphylococcus aureus osteomyelitis with combination therapy using linezolid and rifampicin under therapeutic drug monitoring
- (2016) Nobuyuki Ashizawa et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Achieving Target Voriconazole Concentrations More Accurately in Children and Adolescents
- (2015) Michael Neely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens
- (2015) George G. Zhanel et al. DRUGS
- Prolonged inductive effect of rifampicin on linezolid exposure
- (2015) Cristina Gervasoni et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetics of linezolid treatment using intravenous and oral administrations in extremely premature infants
- (2015) Mélanie Sicard et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective study: TABLE 1
- (2015) Mathieu S. Bolhuis et al. EUROPEAN RESPIRATORY JOURNAL
- Drug–drug interactions and safety of linezolid, tedizolid, and other oxazolidinones
- (2015) Antonios Douros et al. Expert Opinion on Drug Metabolism & Toxicology
- Potential Drug Interaction between Warfarin and Linezolid
- (2015) Yoshiro Sakai et al. INTERNAL MEDICINE
- Linezolid extracorporeal removal during haemodialysis with high cut-off membrane in critically ill patients
- (2015) Gianluca Villa et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Is it time to revise linezolid doses in peritoneal dialysis patients? A case series
- (2015) Cristina Gervasoni et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics of high dosage of linezolid in two morbidly obese patients: Figure 1.
- (2015) Silvia Corcione et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population pharmacokinetics of linezolid in critically ill patients on renal replacement therapy: comparison of equal doses in continuous venovenous haemofiltration and continuous venovenous haemodiafiltration
- (2015) C. Roger et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The association between risk factors and time of onset for thrombocytopenia in Japanese patients receiving linezolid therapy: a retrospective analysis
- (2015) T. Ichie et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Pharmacokinetics and preliminary safety of high dose linezolid for the treatment of Gram-positive bacterial infections
- (2015) Belén Lopez-Garcia et al. JOURNAL OF INFECTION
- Linezolid dosage in pediatric patients based on pharmacokinetics and pharmacodynamics
- (2015) Kazuaki Matsumoto et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients—A Prospective, Randomized Study
- (2015) Elisabet Størset et al. TRANSPLANTATION
- Role of therapeutic drug monitoring in pulmonary infections: use and potential for expanded use of dried blood spot samples
- (2015) Susan Hofman et al. Bioanalysis
- Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infections
- (2015) Ronald G Hall et al. Infection and Drug Resistance
- Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains
- (2015) T. Weiss et al. EUROPEAN RESPIRATORY JOURNAL
- Pharmacokinetics of Tedizolid in Subjects with Renal or Hepatic Impairment
- (2014) S. Flanagan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Analysis of the Phase 3 ESTABLISH Trials of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections
- (2014) Andrew F. Shorr et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tedizolid Population Pharmacokinetics, Exposure Response, and Target Attainment
- (2014) S. Flanagan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Population Pharmacokinetics and Toxicodynamics of Linezolid
- (2014) Lauren M. Boak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Single-dose linezolid pharmacokinetics in critically ill patients with impaired renal function especially chronic hemodialysis patients
- (2014) Mona I. El-Assal et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Reduction of linezolid-associated thrombocytopenia by the dose adjustment based on the risk factors such as basal platelet count and body weight
- (2014) Takashi Niwa et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Linezolid update: Stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms
- (2014) Rodrigo E. Mendes et al. DRUG RESISTANCE UPDATES
- Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients
- (2014) Kazuaki Matsumoto et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Developments in the pharmacokinetic/pharmacodynamic index of linezolid: a step toward dose optimization using Monte Carlo simulation in critically ill patients
- (2014) Haiyan Dong et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation
- (2014) P. Cojutti et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- New Potent Antibacterial Oxazolidinone (MRX-I) with an Improved Class Safety Profile
- (2014) Mikhail F. Gordeev et al. JOURNAL OF MEDICINAL CHEMISTRY
- Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
- (2014) Jason A Roberts et al. LANCET INFECTIOUS DISEASES
- Single- and Multiple-Dose Pharmacokinetics and Absolute Bioavailability of Tedizolid
- (2014) Shawn Flanagan et al. PHARMACOTHERAPY
- Intracellular activity of tedizolid phosphate and ACH-702 versus Mycobacterium tuberculosis infected macrophages
- (2014) Carmen A Molina-Torres et al. Annals of Clinical Microbiology and Antimicrobials
- Clinical Validation of the Analysis of Linezolid and Clarithromycin in Oral Fluid of Patients with Multidrug-Resistant Tuberculosis
- (2013) M. S. Bolhuis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tedizolid Phosphate for the Management of Acute Bacterial Skin and Skin Structure Infections: Efficacy Summary
- (2013) W. O'Riordan et al. CLINICAL INFECTIOUS DISEASES
- Use of Pharmacokinetic/Pharmacodynamic Systems Analyses to Inform Dose Selection of Tedizolid Phosphate
- (2013) Thomas P. Lodise et al. CLINICAL INFECTIOUS DISEASES
- Linezolid-induced thrombocytopenia in impaired renal function: is it time for a dose adjustment? A case report and review of literature
- (2013) A. P. Cossu et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients
- (2013) Mathieu S. Bolhuis et al. EUROPEAN RESPIRATORY JOURNAL
- Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with Gram-positive infections
- (2013) Dario Cattaneo et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia
- (2013) Y. Nukui et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population Pharmacokinetic Analysis of Linezolid in Low Body Weight Patients with Renal Dysfunction
- (2013) Yasuhiro Tsuji et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetics and Elimination Efficiency of Linezolid during Dialysis
- (2013) Yoichi Hiraki et al. RENAL FAILURE
- Linezolid for the treatment of drug-resistant tuberculosis in children: A review and recommendations
- (2013) Anthony J. Garcia-Prats et al. TUBERCULOSIS
- Pulmonary Disposition of Tedizolid following Administration of Once-Daily Oral 200-Milligram Tedizolid Phosphate in Healthy Adult Volunteers
- (2012) Seth T. Housman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Intravenous Linezolid in Moderately to Morbidly Obese Adults
- (2012) Amira A. Bhalodi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Clinical Relevance of Plasma Protein Binding Changes
- (2012) Jason A. Roberts et al. CLINICAL PHARMACOKINETICS
- Efficacy and safety of meropenem–clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB
- (2012) Saverio De Lorenzo et al. EUROPEAN RESPIRATORY JOURNAL
- Skin and soft tissue concentrations of tedizolid (formerly torezolid), a novel oxazolidinone, following a single oral dose in healthy volunteers
- (2012) Martina Sahre et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Oral bioavailability of linezolid before and after Roux-en-Y gastric bypass surgery: is dose modification necessary in obese subjects?
- (2012) R. Hamilton et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients
- (2012) W.-J. Koh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients
- (2012) F. Pea et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis
- (2012) Myungsun Lee et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of the pharmacokinetics of linezolid in an obese Japanese patient
- (2012) Yasuhiro Tsuji et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- The oxazolidinones: past, present, and future
- (2011) Karen Joy Shaw et al. Annals of the New York Academy of Sciences
- Impact of Granulocytes on the Antimicrobial Effect of Tedizolid in a Mouse Thigh Infection Model
- (2011) G. L. Drusano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Use of linezolid in neonatal and pediatric inpatient facilities—results of a retrospective multicenter survey
- (2011) A. Simon et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis
- (2011) M. Villar et al. EUROPEAN RESPIRATORY JOURNAL
- Linezolid Pharmacokinetics in Patients With Acute Renal Failure Undergoing Continuous Venovenous Hemodiafiltration
- (2011) Esther Carcelero et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Correlation between serum linezolid concentration and the development of thrombocytopenia
- (2011) Yoichi Hiraki et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Comparison of the Pharmacokinetics of Two Dosage Regimens of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Patients
- (2010) Jan-Willem C. Alffenaar et al. CLINICAL PHARMACOKINETICS
- Pharmacological Issues of Linezolid
- (2010) Antonello Di Paolo et al. CLINICAL PHARMACOKINETICS
- Clinical efficacy and tolerability of linezolid in pediatric patients: A systematic review
- (2010) Elena Chiappini et al. CLINICAL THERAPEUTICS
- Linezolid treatment of nosocomial bacterial infection with multiresistant Gram-positive pathogens in preterm infants: a systematic review
- (2010) S. Kocher et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction
- (2010) Kazuaki Matsumoto et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction
- (2010) Yasuhiro Tsuji et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Limited Sampling Strategies for Therapeutic Drug Monitoring of Linezolid in Patients With Multidrug-Resistant Tuberculosis
- (2010) Jan-Willem C Alffenaar et al. THERAPEUTIC DRUG MONITORING
- What is the optimal dosage of linezolid in treatment of complicated multidrug-resistant tuberculosis?
- (2009) W. W. Yew et al. EUROPEAN RESPIRATORY JOURNAL
- A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis
- (2009) G. B. Migliori et al. EUROPEAN RESPIRATORY JOURNAL
- Update on the safety of linezolid
- (2009) Eugenios I Metaxas et al. Expert Opinion On Drug Safety
- Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis
- (2009) W. W. Yew et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population Pharmacokinetic Analysis of Linezolid in Patients With Infectious Disease: Application to Lower Body Weight and Elderly Patients
- (2009) Sadahiro Abe et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetics and tolerance of linezolid for meticillin-resistant Staphylococcus aureus mediastinitis in paediatric patients
- (2008) Tadashi Kosaka et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Practical Therapeutic Drug Management in HIV-Infected Patients: Use of Population Pharmacokinetic Models Supplemented by Individualized Bayesian Dose Optimization
- (2008) Michael Neely et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetics of repeated dosing of linezolid in a hemodialysis patient with chronic renal failure
- (2008) Yasuhiro Tsuji et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search